Before any booking
A practical, non-clinical checklist for people and families comparing low-cost ibogaine programs abroad: confirm what is documented, who is responsible, and what happens if plans change.
Safety before price
First pass
A lower quoted price can make a program feel accessible, but it does not answer what has been included, omitted, or delegated. Use the wider Rillstone guide to cost and safety trade-offs as context, then ask each provider for concrete, reviewable answers before making travel arrangements.
Screening file
Ask what screening tests are requested and whether you can receive or retain copies of the records that are reviewed.
People and roles
Ask who conducts screening, who is physically present during treatment, and how a physician is involved. General descriptions are not a substitute for named roles and a clear process.
Emergency planning
Request a plain explanation of monitoring, emergency supplies, nearby hospital transfer arrangements, and how family members would be informed if urgent care were needed.
The review bench
Before departure, discuss your health history, medication list, and travel plans with a qualified clinician who can assess your individual circumstances. This checklist does not create a medical protocol and cannot replace professional evaluation.
Medication history matters because ibogaine has known safety concerns, including cardiac risk. The National Center for Biotechnology Information’s ibogaine overview describes reported toxicities and helps explain why a provider’s willingness to review history carefully is material, not administrative.
For plain background while preparing questions, compare descriptions of ibogaine therapy with what a program says it actually provides. If its answers cannot be documented or independently understood, pause before treating a lower price as a meaningful comparison.
“The useful question is not whether a program sounds reassuring. It is whether its safeguards can be described, documented, and checked before travel.”
Proof before departure
Cost comparison can obscure omissions. A program may use broad language about care while leaving the practical details unresolved. For a wider view of how programs differ, review the questions used when comparing ibogaine treatment centers; the aim is not to endorse a provider, but to make missing information easier to notice.
Ibogaine is a psychoactive substance derived from the iboga plant, and the background on ibogaine can help distinguish general terminology from evidence of a specific program’s safeguards. A provider’s claims should always return to their documented process, your individual medical review, and a credible emergency plan.
It is reasonable to ask how a program handles a change in eligibility after screening, a delayed flight, a worsening health concern, or an early return home. These are ordinary planning questions, especially where a low-cost arrangement may leave little margin for added support.
Travel is part of the plan
Mexico and Costa Rica are common destinations in conversations about ibogaine. Travel arrangements should be made only after the program has answered the health and emergency questions above. A retreat setting, a low fare, or a short itinerary does not answer them.
Before travel, check current entry requirements and consular guidance through the U.S. State Department’s Mexico country information. Keep transport, lodging, local support, and a plan for changes to your itinerary separate from the provider’s treatment description.
When comparing a Mexico ibogaine retreat, ask what responsibility the program accepts for arrivals, departures, recovery time, and urgent transport—and what it does not accept.
Confirm current entry, health, and local travel information through the U.S. State Department’s Costa Rica country information before booking. Requirements and conditions can change, and no general checklist can determine what applies to an individual traveler.
Consider the practical return journey as well: whether someone can travel with you, where you would stay if plans shift, and how you would access independent help outside the program.
Practical questions
Questions are useful when they produce usable answers. Keep notes, ask for clarification in writing where possible, and do not treat this resource as medical or legal advice.
Ask for written confirmation of what screening records the program requires, who reviews them, what monitoring is available, and what emergency transfer plan is in place. If you are comparing ibogaine treatment locations, make the same request each time so the answers can be compared on like terms.
Ask what is included before, during, and after the stay; who is present; what happens if someone cannot proceed; and what support is or is not provided after departure. Accounts of an ibogaine trip experience may describe personal impressions, but they do not replace a provider’s documented safety process.
Do not assume that a destination, a website, or a research reference settles legal or medical questions. For example, information about an ibogaine clinical trial in Texas is distinct from the services offered by a program abroad. Verify legal and travel conditions with appropriate official sources, and discuss health questions with a qualified clinician.
Take avoidance seriously. A concise explanation of ibogaine as a psychedelic drug can help frame basic questions, but a provider should still be able to explain its own screening, monitoring, staffing roles, transfer plan, and limits in plain language.
Keep the record
Save each answer, identify what remains unconfirmed, and give independent medical review time before travel. Careful preparation cannot remove uncertainty, but it can make omissions visible before money changes hands.
Review safety trade-offs